The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset

Sudden sensorineural hearing loss (SSNHL) is an acquired idiopathic hearing loss. Serum levels of small, non-coding RNAs and microRNAs (miRNAs) miR-195-5p/-132-3p/-30a-3p/-128-3p/-140-3p/-186-5p/-375-3p/-590-5p are differentially expressed in SSNHL patients within 28 days of hearing loss onset. This...

Full description

Bibliographic Details
Main Authors: Reyhaneh Abgoon, Printha Wijesinghe, Cathie Garnis, Desmond A. Nunez
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/8/7307
_version_ 1797605117549084672
author Reyhaneh Abgoon
Printha Wijesinghe
Cathie Garnis
Desmond A. Nunez
author_facet Reyhaneh Abgoon
Printha Wijesinghe
Cathie Garnis
Desmond A. Nunez
author_sort Reyhaneh Abgoon
collection DOAJ
description Sudden sensorineural hearing loss (SSNHL) is an acquired idiopathic hearing loss. Serum levels of small, non-coding RNAs and microRNAs (miRNAs) miR-195-5p/-132-3p/-30a-3p/-128-3p/-140-3p/-186-5p/-375-3p/-590-5p are differentially expressed in SSNHL patients within 28 days of hearing loss onset. This study determines if these changes persist by comparing the serum miRNA expression profile of SSNHL patients within 1 month of hearing loss onset with that of patients 3–12 months after hearing loss onset. We collected serum from consenting adult SSNHL patients at presentation or during clinic follow-up. We matched patient samples drawn 3–12 months after hearing loss onset (delayed group, <i>n</i> = 9 patients) by age and sex to samples drawn from patients within 28 days of hearing loss onset (immediate group, <i>n</i> = 14 patients). We compared the real-time PCR-determined expression levels of the target miRNAs between the two groups. We calculated the air conduction pure-tone-averaged (PTA) audiometric thresholds in affected ears at the initial and final follow-up visits. We undertook inter-group comparisons of hearing outcome status and initial and final PTA audiometric thresholds. There was no significant inter-group difference in miRNA expression level, hearing recovery status and initial and final affected ear PTA audiometric thresholds.
first_indexed 2024-03-11T04:56:36Z
format Article
id doaj.art-ed48275b91ea4ee9851b4d00cdc79655
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T04:56:36Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ed48275b91ea4ee9851b4d00cdc796552023-11-17T19:38:28ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-04-01248730710.3390/ijms24087307The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss OnsetReyhaneh Abgoon0Printha Wijesinghe1Cathie Garnis2Desmond A. Nunez3Division of Otolaryngology, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, CanadaDivision of Otolaryngology, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, CanadaDivision of Otolaryngology, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, CanadaDivision of Otolaryngology, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, CanadaSudden sensorineural hearing loss (SSNHL) is an acquired idiopathic hearing loss. Serum levels of small, non-coding RNAs and microRNAs (miRNAs) miR-195-5p/-132-3p/-30a-3p/-128-3p/-140-3p/-186-5p/-375-3p/-590-5p are differentially expressed in SSNHL patients within 28 days of hearing loss onset. This study determines if these changes persist by comparing the serum miRNA expression profile of SSNHL patients within 1 month of hearing loss onset with that of patients 3–12 months after hearing loss onset. We collected serum from consenting adult SSNHL patients at presentation or during clinic follow-up. We matched patient samples drawn 3–12 months after hearing loss onset (delayed group, <i>n</i> = 9 patients) by age and sex to samples drawn from patients within 28 days of hearing loss onset (immediate group, <i>n</i> = 14 patients). We compared the real-time PCR-determined expression levels of the target miRNAs between the two groups. We calculated the air conduction pure-tone-averaged (PTA) audiometric thresholds in affected ears at the initial and final follow-up visits. We undertook inter-group comparisons of hearing outcome status and initial and final PTA audiometric thresholds. There was no significant inter-group difference in miRNA expression level, hearing recovery status and initial and final affected ear PTA audiometric thresholds.https://www.mdpi.com/1422-0067/24/8/7307sudden sensorineural hearing lossmicroRNAsserum
spellingShingle Reyhaneh Abgoon
Printha Wijesinghe
Cathie Garnis
Desmond A. Nunez
The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset
International Journal of Molecular Sciences
sudden sensorineural hearing loss
microRNAs
serum
title The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset
title_full The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset
title_fullStr The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset
title_full_unstemmed The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset
title_short The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset
title_sort expression levels of micrornas differentially expressed in sudden sensorineural hearing loss patients serum are unchanged for up to 12 months after hearing loss onset
topic sudden sensorineural hearing loss
microRNAs
serum
url https://www.mdpi.com/1422-0067/24/8/7307
work_keys_str_mv AT reyhanehabgoon theexpressionlevelsofmicrornasdifferentiallyexpressedinsuddensensorineuralhearinglosspatientsserumareunchangedforupto12monthsafterhearinglossonset
AT printhawijesinghe theexpressionlevelsofmicrornasdifferentiallyexpressedinsuddensensorineuralhearinglosspatientsserumareunchangedforupto12monthsafterhearinglossonset
AT cathiegarnis theexpressionlevelsofmicrornasdifferentiallyexpressedinsuddensensorineuralhearinglosspatientsserumareunchangedforupto12monthsafterhearinglossonset
AT desmondanunez theexpressionlevelsofmicrornasdifferentiallyexpressedinsuddensensorineuralhearinglosspatientsserumareunchangedforupto12monthsafterhearinglossonset
AT reyhanehabgoon expressionlevelsofmicrornasdifferentiallyexpressedinsuddensensorineuralhearinglosspatientsserumareunchangedforupto12monthsafterhearinglossonset
AT printhawijesinghe expressionlevelsofmicrornasdifferentiallyexpressedinsuddensensorineuralhearinglosspatientsserumareunchangedforupto12monthsafterhearinglossonset
AT cathiegarnis expressionlevelsofmicrornasdifferentiallyexpressedinsuddensensorineuralhearinglosspatientsserumareunchangedforupto12monthsafterhearinglossonset
AT desmondanunez expressionlevelsofmicrornasdifferentiallyexpressedinsuddensensorineuralhearinglosspatientsserumareunchangedforupto12monthsafterhearinglossonset